Login to Your Account



Washington Roundup

Committee to Ponder Tumor Cells for Vaccine Manufacture

By Catherine Shaffer
Staff Writer

Tuesday, September 18, 2012
The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) released briefing documents in advance of its Wednesday meeting to discuss the use of cell lines derived from human tumors for vaccine manufacture.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription